XTL BIOPHARMACEUTICALS LTD. Basic Earnings Loss Per Share
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Basic Earnings Loss Per Share of -$0.00 per share for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2025-04-30
- XTL BIOPHARMACEUTICALS LTD. basic earnings loss per share for the quarter ending 2022-06-30 was -$0.00.
- XTL BIOPHARMACEUTICALS LTD. basic earnings loss per share for the quarter ending 2021-06-30 was -$0.00.
| Period end | Basic Earnings Loss Per Share 3 month | Basic Earnings Loss Per Share 6 month | Basic Earnings Loss Per Share 12 month |
|---|---|---|---|
| 2024-12-31 | -$0.00 20-F · filed 2025-04-30 | ||
| 2023-12-31 | -$0.00 20-F · filed 2025-04-30 | ||
| 2022-12-31 | -$0.00 20-F · filed 2025-04-30 | ||
| 2022-06-30 | -$0.00 6-K · filed 2022-08-24 | $0.00 6-K · filed 2022-08-24 | |
| 2021-12-31 | $0.00 20-F · filed 2023-03-22 | ||
| 2021-06-30 | -$0.00 6-K · filed 2022-08-24 | -$0.00 6-K · filed 2022-08-24 | |
| 2020-12-31 | -$0.01 20-F · filed 2023-03-22 | ||
| 2019-12-31 | -$0.00 20-F · filed 2022-03-30 |